POLB — Poolbeg Pharma Share News
0.000.00%
Last trade - 00:00
- £64.50m
- £52.33m
RCS - Poolbeg Pharma PLC - Attendance at European Melioidosis Congress
AnnouncementREG - Poolbeg Pharma PLC - Distribution in Specie update
AnnouncementREG - Poolbeg Pharma PLC - Key POLB 002 European Patent Granted
AnnouncementREG - Poolbeg Pharma PLC - Distribution in Specie Shareholders
AnnouncementREG - Poolbeg Pharma PLC - Result of AGM
AnnouncementREG - Poolbeg Pharma PLC - POLB001 Update - Clinical Trial Agreement Signed
AnnouncementREG - Poolbeg Pharma PLC - Commencement of trading on US OTCQB market
AnnouncementREG - Poolbeg Pharma PLC - AI deal signed with CytoReason
AnnouncementREG - Poolbeg Pharma PLC - Notice of AGM
AnnouncementREG - Poolbeg Pharma PLC - Final Results
AnnouncementREG - Poolbeg Pharma PLC - Notice of Results
AnnouncementREG - Poolbeg Pharma PLC - Artificial Intelligence deal with OneThree Biotech
AnnouncementREG - Poolbeg Pharma PLC - Confirmation of vaccine platform licence execution
AnnouncementREG - Poolbeg Pharma PLC - Exclusive license of RNA-based immunotherapy asset
AnnouncementREG - Poolbeg Pharma PLC - Poolbeg to develop oral vaccine delivery platform
AnnouncementREG - Poolbeg Pharma PLC - Poolbeg signs option for new vaccine candidate
AnnouncementREG - Poolbeg Pharma PLC - Scientific Advisory Board Appointment
AnnouncementREG - Poolbeg Pharma PLC - Update on POLB 001 Clinical Development
AnnouncementREG - Poolbeg Pharma PLC - Second Price Monitoring Extn
Announcement